Key factors in Alzheimer's disease: β-Amyloid precursor protein processing, metabolism and intraneuronal transport

Brain Pathology

Volumn 11, Issue 1, 2001, Pages 1-11

  Bayer, Thomas A ^a   Wirths, Oliver ^a   Majtényi, Katalin ^b   Hartmann, Tobias ^c   Multhaup, Gerd ^c   Beyreuther, Konrad ^c   Czech, Christian ^d,e  

^a UNIVERSITY HOSPITAL BONN   (Germany)

^b National Institute for Nervous and Mental Diseases   (Hungary)

^c ZMBH   (Germany)

^d SANOFI   (France)

^e NAP AG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID BETA PROTEIN; AMYLOID PRECURSOR PROTEIN;

ALZHEIMER DISEASE; APOPTOSIS; DEGENERATIVE DISEASE; HUMAN; NEUROLOGIC DISEASE; NEUROTOXICITY; PROTEIN DEGRADATION; PROTEIN STRUCTURE; PROTEIN TRANSPORT; REVIEW;

EID: 0035203662     PISSN: 10156305     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1750-3639.2001.tb00376.x     Document Type: Review

References (88)

1. Uber eine eigenartige erkrankung der hirnrinde
2. It all sticks together-the APP-related family of proteins and Alzheimer's disease
3. Plaque formation in brain transplants exposed to human beta-amyloid precursor protein 695
4. Mechanisms of amyloid deposition in Alzheimer's disease
5. Copper inhibits beta-amyloid production and stimulates the non- amyloidogenic pathway of amyloid-precursor-protein secretion
6. The phosphotyrosine interaction domains of X11 and FE65 bind to distinct sites on the YENPTY motif of amyloid precursor protein
7. The X11alpha protein slows cellular amyloid precursor protein processing and reduces Abeta40 and Abeta42 secretion
8. Regulation of APP processing by intra- and intercellular signals
9. Evidence that tumor necrosis factor alpha converting enzyme is involved in regulated alpha-secretase cleavage of the Alzheimer amyloid protein precursor
10. Release of excess amyloid β protein from a mutant amyloid protein precursor
11. Neuron loss in APP transgenic mice
12. Impaired synaptic plasticity and learning in aged amyloid precursor protein transgenic mice
13. Mutation of the β-amyloid precursor protein in familial Alzheimer's disease increases β-protein production
14. Alzheimer's A beta(1-42) is generated in the endoplasmic reticulum/intermediate compartment of NT2N cells
15. What the evolution of the amyloid protein precursor supergene family tells us about its function
16. Presenilins and Alzheimer's disease: Biological functions and pathogenic mechanisms
17. Study of the synthesis and secretion of normal and artificial mutants of murine amyloid precursor protein (APP): Cleavage of APP occurs in a late compartment of the default secretion pathway
18. The beta-amyloid precursor protein and its derivatives: From biology to learning and memory processes
19. Reverse relationship between beta-amyloid precursor protein and beta- amyloid peptide plaques in Down's syndrome versus sporadic/familial Alzheimer's disease
20. BACE2, a beta-secretase homolog, cleaves at the beta site and within the amyloid-beta region of the amyloid-beta precursor protein
21. The regions of the Fe65 protein homologous to the phosphotyrosine interaction/phosphotyrosine binding domain of Shc bind the intracellular domain of the Alzheimer's amyloid precursor protein
22. Transgenic Drosophila expressing human amyloid precursor protein show gamma-secretase activity and a blistered-wing phenotype
23. Alzheimer-type neuropathology in transgenic mice overexpressing V717F beta-amyloid precursor protein
24. Alzheimer's disease: Initial report of the purification and characterization of a novel cerebrovasular amyloid protein
25. The amyloid deposits in Alzheimer's disease: Their nature and pathogenesis
26. Intraneuronal Abeta42 accumulation in human brain
27. Endoplasmic reticulum and trans-Golgi network generate distinct populations of Alzheimer beta-amyloid peptides
28. Progress toward valid transgenic mouse models for Alzheimer's disease
29. The presenilins in Alzheimer's disease-proteolysis holds the key
30. Amyloid beta-peptide is produced by cultured cells during normal metabolism
31. Distinct sites of intracellular production for Alzheimer's disease A beta40/42 amyloid peptides
32. Assessing the machinery of mind: Synapses in neuropsychiatric disorders
33. Membrane protein secretases
34. Plaque-independent disruption of neural circuits in Alzheimer's disease mouse models
35. Transgenic mice expressing Alzheimer amyloid precursor proteins
36. Correlative memory deficits, Abeta elevation, and amyloid plaques in transgenic mice
37. Synaptic beta-amyloid precursor proteins increase with learning capacity in rats
38. APPSw transgenic mice develop age-related Abeta deposits and neuropil abnormalities, but no neuronal loss in CA1
39. Neuropathology of Alzheimer's disease: A critical update
40. Antibodies to non-beta regions of the beta-amyloid precursor protein detect a subset of senile plaques
41. Amyloid precursor protein processing and A beta42 deposition in a transgenic mouse model of Alzheimer disease
42. The precursor of Alzheimer's disease amyloid A4 protein resembles a cell surface receptor
43. Alternative splicing of the βA4 amyloid gene of Alzheimer's Disease in cortex of control and Alzheimer's disease patients
44. Cellular signaling pathways and cytoskeletal organization
45. The Alzheimer beta-amyloid protein precursor/protease nexin-II is cleaved by secretase in a trans-Golgi secretory compartment in human neuroglioma cells
46. Constitutive and regulated alpha-secretase cleavage of Alzheimer's amyloid precursor protein by a disintegrin metalloprotease
47. Human ADAM 12 (meltrin alpha) is an active metalloprotease
48. Cerebral amyloidosis aging and Alzheimer's disease: A contribution from studies on Down's syndrome
49. Mechanisms of synaptic pathology in Alzheimer's disease
50. Amyloid plaque core protein in Alzheimer disease and Down syndrome
51. Early phenotypic changes in transgenic mice that overexpress different mutants of amyloid precursor protein in brain
52. Expression in brain of amyloid precursor protein mutated in the alpha- secretase site causes disturbed behavior, neuronal degeneration and premature death in transgenic mice
53. Premature death in transgenic mice that overexpress a mutant amyloid precursor protein is preceded by severe neurodegeneration and apoptosis
54. Alzheimer beta A4-amyloid protein precursor in immunocompetent cells
55. The molecular genetics of Alzheimer's disease
56. The amyloid precursor protein of Alzheimer's disease in the reduction of copper(II) to copper(I)
57. Mutant mice with sampled brains: Understanding the signaling pathways that control cell positioning in the CNS
58. The regulation of amyloid precursor protein metabolism by cholinergic mechanisms and neurotrophin receptor signaling
59. Alzheimer's disease families with amyloid precursor protein mutations
60. Regulation of beta-amyloid secretion by FE65, an amyloid protein precursor-binding protein
61. The Alzheimer's amyloid precursor is cleaved intracellularly in the trans-Golgi network or in a post-Golgi compartment
62. APP gene family: Unique age-associated changes in splicing of Alzheimer's βA4-amyloid protein precursor
63. X11 interaction with beta-amyloid precursor protein modulates its cellular stabilization and reduces amyloid beta-protein secretion
64. Cell biology of the amyloid β-protein precursor and the mechanism of Alzheimer's disease
65. The role of APP processing and trafficking pathways in the formation of amyloid beta-protein
66. Amyloidogenic processing of the human amyloid precursor protein in primary cultures of rat hippocampal neurons
67. Intracellular routing of human amyloid protein precursor: Axonal delivery followed by transport to the dendrites
68. Cellular mechanisms of beta-amyloid production and secretion
69. Detection of a novel intraneuronal pool of insoluble amyloid beta protein that accumulates with time in culture
70. The role of the amyloid protein precursor (APP) in Alzheimer's disease: Does the normal function of APP explain the topography of neurodegeneration?
71. Two amyloid precursor protein transgenic mouse models with Alzheimer disease-like pathology
72. Transgenic animals in Alzheimer's disease research
73. Presenilin 1 mutations linked to familial Alzheimer's disease increase the intracellular levels of amyloid beta-protein 1-42 and its N-terminally truncated variant(s) which are generated at distinct sites
74. The amyloid β protein gene: cDNA cloning, mRNA distribution, and genetic linkage near the Alzheimer locus
75. Neuronal sorting and processing of amyloid precursor protein: Implications for Alzheimer's disease
76. The b-amyloid domain is essential for axonal sorting of amyloid precursor protein
77. A basic amino acid in the cytoplasmic domain of Alzheimer's beta-amyloid precursor protein (APP) is essential for cleavage of APP at the alpha-site
78. The Drosophila beta-amyloid precursor protein homolog promotes synapse differentiation at the neuromuscular junction
79. Beta-secretase cleavage of Alzheimer's amyloid precursor protein by the transmembrane aspartic protease BACE
80. Human neurons derived from a teratocarcinoma cell line express solely the 695-amino acid amyloid precursor protein and produce intracellular beta-amyloid or A4 peptides
81. The Alzheimer's disease amyloid precursor protein modulates copper-induced toxicity and oxidative stress in primary neuronal cultures
82. Copper levels are increased in the cerebral cortex and liver of APP and APLP2 knockout mice
83. Intracellular generation and accumulation of amyloid beta-peptide terminating at amino acid 42
84. Intracellular APP processing and A beta production in Alzheimer disease
85. Peptidomimetic probes and molecular modeling suggest that Alzheimer's gamma-secretase is an intramembrane-cleaving aspartyl protease
86. Presenilin 1 regulates the processing of beta-amyloid precursor protein C-terminal fragments and the generation of amyloid beta-protein in endoplasmic reticulum and Golgi
87. Membrane-anchored aspartyl protease with Alzheimer's disease beta-secretase activity
88. Intracellular accumulation of insoluble, newly synthesized abeta-42 in amyloid precursor protein-transfected cells that have been treated with Abeta1-42